XML 53 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Estimated Useful Life of Property, Plant and Equipment

Asset group

 

Term

Buildings and improvements

 

15 - 40 years

Furniture, fixtures and equipment

 

3 - 10 years

Leasehold improvements

 

Shorter of useful life or lease term

Schedule of Contract Assets and Contract Liabilities

Contract assets consisted of the following:

 

(In thousands)

 

Contract Assets

 

Contract assets at January 1, 2022

 

$

13,363

 

Additions

 

 

42,218

 

Transferred to receivables, net

 

 

(46,652

)

Contract assets at December 31, 2022

 

$

8,929

 

Additions

 

 

13,606

 

Transferred to receivables, net

 

 

(21,829

)

Contract assets at December 31, 2023

 

$

706

 

Contract liabilities consisted of the following:

 

(In thousands)

 

Contract Liabilities

 

Contract liabilities at January 1, 2022

 

$

17,830

 

Additions

 

 

6,769

 

Amounts recognized into revenue

 

 

(7,514

)

Amounts recognized into other (expense) income, net

 

 

(6,384

)

Contract liabilities at December 31, 2022

 

$

10,701

 

Reductions

 

 

(931

)

Amounts recognized into revenue

 

 

(4,995

)

Contract liabilities at December 31, 2023

 

$

4,775

 

Schedule of Revenue and Receivables From Customers Exceeding 10% of Total in Each Category The following represents revenue and receivables from the Company’s customers exceeding 10% of the total in each category as of, and for the years ended, December 31, 2023, 2022 and 2021:

 

 

 

Year Ended December 31,

 

 

 

2023

 

2022

 

2021

 

Customer

 

Receivables

 

Revenue

 

Receivables

 

Revenue

 

Receivables

 

Revenue

 

Janssen

 

23

%

31

%

*

 

15

%

30

%

30

%

Biogen

 

9

%

11

%

19

%

13

%

11

%

10

%

Cardinal Health

 

24

%

20

%

24

%

24

%

17

%

20

%

AmerisourceBergen

 

16

%

12

%

18

%

14

%

13

%

11

%

McKesson

 

14

%

14

%

12

%

16

%

11

%

13

%

 

*

 

Indicates the revenues or receivables for the customer did not exceed 10% of the Company’s total in each category as of or for the years ended December 31, 2023, 2022 and 2021, as noted.

Schedule of Revenues by Geographic Location, as Determined by the Location of the Customer

Company revenues by geographic location for the years ended December 31, 2023, 2022 and 2021, as determined by the location of the customer, are as follows:

 

 

 

Year Ended December 31,

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Revenue by region:

 

 

 

 

 

 

 

 

 

U.S.

 

$

1,491,939

 

 

$

931,991

 

 

$

984,235

 

Ireland

 

 

1,179

 

 

 

1,829

 

 

 

2,175

 

Rest of world

 

 

170,287

 

 

 

177,975

 

 

 

187,341

 

Summary of Location of the Assets

The location of the Company’s assets are as follows:

 

 

 

December 31,

 

(In thousands)

 

2023

 

 

2022 (1)

 

Assets by region:

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

U.S.:

 

 

 

 

 

 

Assets related to discontinued operations

 

$

 

 

$

2,324

 

Other current assets

 

 

867,588

 

 

 

700,240

 

Ireland:

 

 

 

 

 

 

Assets held for sale

 

$

94,260

 

 

$

 

Other current assets

 

 

523,658

 

 

 

427,742

 

Rest of world

 

 

 

 

 

 

Long-term assets:

 

 

 

 

 

 

U.S.:

 

 

 

 

 

 

Assets related to discontinued operations

 

$

 

 

$

37,763

 

Other

 

 

432,870

 

 

 

499,038

 

Ireland:

 

 

 

 

 

 

Intangible assets

 

$

1,991

 

 

$

37,680

 

Assets held for sale

 

 

 

 

 

93,871

 

Goodwill

 

 

83,027

 

 

 

83,027

 

Other

 

 

132,829

 

 

 

82,293

 

 

(1)
Prior period amounts have been retrospectively adjusted to reflect assets related to discontinued operations related to the Separation and assets held for sale related to the planned sale of the Athlone Facility.
Schedule of Fair Value of Each Stock Option Granted Estimated on The Grant Date Using Weighted-average Assumptions

The fair value of each stock option granted was estimated on the grant date with the following weighted-average assumptions:

 

 

 

Year Ended December 31,

 

 

2023

 

2022

 

2021

Expected option term

 

5 - 8 years

 

5 - 8 years

 

5 - 7 years

Expected stock volatility

 

40 % - 44 %

 

43 % - 51 %

 

43 % - 54 %

Risk-free interest rate

 

3.34 % - 4.75 %

 

1.83 % - 4.26 %

 

0.67 % - 1.46 %

Expected annual dividend yield